Nabriva Therapeutics plc·4

Aug 1, 4:17 PM ET

Talbot George Harrison 4

4 · Nabriva Therapeutics plc · Filed Aug 1, 2019

Insider Transaction Report

Form 4
Period: 2019-07-31
Transactions
  • Award

    Stock Option

    2019-07-31+35,00035,000 total
    Exp: 2029-07-31Ordinary Shares (35,000 underlying)
Footnotes (2)
  • [F1]The exercise price is $2.38 per share.
  • [F2]This option was granted on July 31, 2019. One hundred percent (100%) of the option will vest on July 31, 2020, subject to the reporting person's continued service on the board of directors of Nabriva Therapeutics plc.

Documents

1 file
  • 4
    a4.xmlPrimary

    4